Free Trial
NYSE:BME

BlackRock Health Sciences Trust (BME) Stock Price, News & Analysis

$41.96
+0.37 (+0.89%)
(As of 11:09 AM ET)
Today's Range
$41.61
$41.98
50-Day Range
$39.38
$41.59
52-Week Range
$35.53
$42.86
Volume
3,782 shs
Average Volume
32,864 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
6.08%
Price Target
N/A
BME stock logo

About BlackRock Health Sciences Trust Stock (NYSE:BME)

BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services. It also invests through equity derivatives, with an emphasis on option writing. The fund benchmarks the performance of its portfolio against the Russell 3000 Healthcare Index. BlackRock Health Sciences Trust was formed on March 31, 2005 and is domiciled in the United States.

BME Stock Price History

BME Stock News Headlines

You're missing out on these earnings plays
FREE Guide: Unlock Earnings Season's Hidden Profits 15+ years of trading wisdom condensed into one powerful strategy. Learn to spot opportunities others miss during Q3 earnings. Daily intel included: Morning briefing, Midday update, Evening report. Claim your free Ultimate Strategy Guide To Trade Earnings Season now.
BME: Historically One Of The Best Times For Entry
You're missing out on these earnings plays
FREE Guide: Unlock Earnings Season's Hidden Profits 15+ years of trading wisdom condensed into one powerful strategy. Learn to spot opportunities others miss during Q3 earnings. Daily intel included: Morning briefing, Midday update, Evening report. Claim your free Ultimate Strategy Guide To Trade Earnings Season now.
Blackrock Health Sciences Trust's Dividend Analysis
BME - BlackRock Health Sciences Trust
Blackrock Health Sciences Trust (NYSE: BME)
See More Headlines
Receive BME Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BlackRock Health Sciences Trust and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 6/28 Dividend
6/14/2024
Dividend Payable
6/28/2024
Ex-Dividend for 7/31 Dividend
7/15/2024
Today
7/16/2024
Dividend Payable
7/31/2024

Industry, Sector and Symbol

Industry
Asset Management
Sub-Industry
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$20.41 million

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Key Executives

  • Mr. Charles Choon Sik Park (Age 57)
    Chief Compliance Officer and Anti-Money Laundering Officer
  • Mr. Thomas P. Callan C.F.A.
    Portfolio Manager
  • Mr. Kyle G. McClements C.F.A.
    Portfolio Manager
  • Dr. Erin Xie Ph.D. (Age 56)
    Portfolio Manager
  • Mr. Christopher M. Accettella
    Portfolio Manager
  • Mr. Jeffrey Gene Lee
    Portfolio Manager
  • Dr. Xiang Liu Ph.D.
    Portfolio Manager

BME Stock Analysis - Frequently Asked Questions

How have BME shares performed this year?

BlackRock Health Sciences Trust's stock was trading at $40.46 at the beginning of the year. Since then, BME stock has increased by 3.7% and is now trading at $41.96.
View the best growth stocks for 2024 here
.

What is Javier Hernani Burzako's approval rating as BlackRock Health Sciences Trust's CEO?

3 employees have rated BlackRock Health Sciences Trust Chief Executive Officer Javier Hernani Burzako on Glassdoor.com. Javier Hernani Burzako has an approval rating of 100% among the company's employees. This puts Javier Hernani Burzako in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Who are BlackRock Health Sciences Trust's major shareholders?

BlackRock Health Sciences Trust's top institutional shareholders include NBC Securities Inc..
View institutional ownership trends
.

How do I buy shares of BlackRock Health Sciences Trust?

Shares of BME stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of BlackRock Health Sciences Trust own?

Based on aggregate information from My MarketBeat watchlists, some other companies that BlackRock Health Sciences Trust investors own include AbbVie (ABBV), Enterprise Products Partners (EPD), AT&T (T), Gilead Sciences (GILD), International Business Machines (IBM), Johnson & Johnson (JNJ) and Verizon Communications (VZ).

This page (NYSE:BME) was last updated on 7/16/2024 by MarketBeat.com Staff

From Our Partners